Paosonelle (Drospirenone, Estradiol Hemihydrate)

Drospirenone, the active ingredient in Paosonelle, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy and manages hormone‑related menstrual disorders in women of reproductive age.

GNH USA supplies Paosonelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paosonelle is a combined oral contraceptive that acts on the hormonal regulation pathway to prevent ovulation. - Contraception: Provides reliable prevention of pregnancy when taken as prescribed. - Menstrual Cycle Regulation: Helps establish a more predictable menstrual cycle. - Acne Management: Reduces acne severity linked to hormonal fluctuations.

Adverse reactions to Paosonelle vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Weight gain: mild fluid retention. - Mood changes: irritability or emotional lability. - Spotting between periods: light vaginal bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke: cerebrovascular accident due to clot or hemorrhage. - Myocardial infarction: heart attack risk, especially in smokers. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzymes.

Before prescribing Paosonelle, clinicians should assess individual risk factors and contraindications. - Smoking status: avoid in women >35 who smoke due to thrombotic risk. - Cardiovascular history: assess for hypertension, clotting disorders, or prior stroke. - Liver function: evaluate for active liver disease. - Migraine history: caution in patients with migraine with aura. - Cancer history: avoid in estrogen‑sensitive malignancies. - Store at ambient temperature: keep below 25°C, in original packaging, protected from moisture.

Paosonelle may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Enzyme inducers (e.g., rifampicin, carbamazepine): reduced contraceptive effectiveness. - Antiretrovirals (e.g., efavirenz): may lower hormone levels.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., fluconazole): possible increased hormone exposure. - Antidepressants (e.g., sertraline): may affect bleeding patterns. - Herbal supplements (e.g., St John’s wort): may diminish efficacy.